Cargando…
Lessons from the failure of the adenovector HIV vaccine
The much-publicised halting of the joint Merck/HIV Vaccine Trials Network phase IIB candidate HIV-1 vaccine trial in 2007 has led to an unprecedented degree of discussion and introspection amongst the HIV research community. In this commentary, we will summarise the lessons learned from the trial an...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biology Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924706/ https://www.ncbi.nlm.nih.gov/pubmed/20948634 http://dx.doi.org/10.3410/B1-50 |
_version_ | 1782185619589431296 |
---|---|
author | Blais, Marie-Eve Rowland-Jones, Sarah |
author_facet | Blais, Marie-Eve Rowland-Jones, Sarah |
author_sort | Blais, Marie-Eve |
collection | PubMed |
description | The much-publicised halting of the joint Merck/HIV Vaccine Trials Network phase IIB candidate HIV-1 vaccine trial in 2007 has led to an unprecedented degree of discussion and introspection amongst the HIV research community. In this commentary, we will summarise the lessons learned from the trial and examine the current state of HIV vaccine research. |
format | Text |
id | pubmed-2924706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Biology Reports Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-29247062010-10-14 Lessons from the failure of the adenovector HIV vaccine Blais, Marie-Eve Rowland-Jones, Sarah F1000 Biol Rep Review Article The much-publicised halting of the joint Merck/HIV Vaccine Trials Network phase IIB candidate HIV-1 vaccine trial in 2007 has led to an unprecedented degree of discussion and introspection amongst the HIV research community. In this commentary, we will summarise the lessons learned from the trial and examine the current state of HIV vaccine research. Biology Reports Ltd 2009-06-29 /pmc/articles/PMC2924706/ /pubmed/20948634 http://dx.doi.org/10.3410/B1-50 Text en © 2009 Biology Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Blais, Marie-Eve Rowland-Jones, Sarah Lessons from the failure of the adenovector HIV vaccine |
title | Lessons from the failure of the adenovector HIV vaccine |
title_full | Lessons from the failure of the adenovector HIV vaccine |
title_fullStr | Lessons from the failure of the adenovector HIV vaccine |
title_full_unstemmed | Lessons from the failure of the adenovector HIV vaccine |
title_short | Lessons from the failure of the adenovector HIV vaccine |
title_sort | lessons from the failure of the adenovector hiv vaccine |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924706/ https://www.ncbi.nlm.nih.gov/pubmed/20948634 http://dx.doi.org/10.3410/B1-50 |
work_keys_str_mv | AT blaismarieeve lessonsfromthefailureoftheadenovectorhivvaccine AT rowlandjonessarah lessonsfromthefailureoftheadenovectorhivvaccine |